(Q46496023)

22 December 2017

title

Dasatinib-induced acute hepatitis (English)

1 reference

22 December 2017

author name string

A Bonvin

1

1 reference

22 December 2017

A Mesnil

2

1 reference

22 December 2017

F E Nicolini

3

1 reference

22 December 2017

L Cotte

4

1 reference

22 December 2017

M Michallet

5

1 reference

22 December 2017

J Descotes

6

1 reference

22 December 2017

T Vial

7

1 reference

22 December 2017

publication date

1 August 2008

1 reference

22 December 2017

published in

Leukemia & Lymphoma

1 reference

22 December 2017

volume

49

1 reference

22 December 2017

issue

8

1 reference

22 December 2017

page(s)

1630-1632

1 reference

22 December 2017

Dasatinib: in chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190802136384

Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802136384

Imatinib mesylate-induced hepato-toxicity in chronic myeloid leukemia demonstrated focal necrosis resembling acute viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802136384

Imatinib mesylate as a cause of acute liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802136384

Fatal hepatic necrosis following imatinib mesylate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802136384

Imatinib-induced immune hepatitis: case report and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802136384

Imatinib mesylate-induced acute hepatitis in a patient treated for gastrointestinal stromal tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802136384

Severe hepatic injury caused by imatinib mesylate administered for the treatment of chronic myeloid leukemia and the efficacy of prednisolone for its management

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802136384

Histological features of acute hepatitis after imatinib mesylate treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802136384

Imatinib mesylate-induced acute cytolytic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802136384

10.1080/10428190802136384

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017